Aim: Opioids are increasingly used to control postoperative pain via intravenous patient-controlled analgesia, with several advantages. The present study evaluated the effects of intravenous patientcontrolled analgesia with different doses of fentanyl on postoperative pain and on the quality of physical/emotional recovery from surgery and anesthesia.
Introduction
Opioids are most frequently used to control postoperative pain. Several routes, including general, epidural, spinal, and local analgesia, have been applied for controlling postoperative pain 1 5 . Opioids administered via intravenous patient-controlled analgesia (IVPCA) have the potential to be used increasingly, with several advantages:
IVPCA has fewer side effects, including nerve damage, epidural hematoma, etc 6 . IVPCA can be administered to patients receiving anticoagulant medication and can achieve pain control equal to those of patient-controlled epidural analgesia. However, no basic guidelines or protocols for preventing side effects have been established, and an optimal method of pain control has not yet been determined.
Advances in anesthetic management and widespread use of minimally invasive surgery, such as laparoscopic cholecystectomy, have reduced morbidity, enhanced recovery, and allowed an earlier resumption of daily activities 7 9 . However, postoperative analgesia is still required in laparoscopic surgery, as postoperative pain could be associated with prolonged hospitalization and increased morbidity 1, 10 .
It has been reported that the majority of patients receiving only periodic oral NSAID treatment after laparoscopic surgery claimed to experience a moderate-to-high level of pain, and continued to report pain even after 1 week postoperatively, indicating a requirement of opioid administration 11 . Taking all into consideration, the optimal regimen of the opioid administration for postoperative analgesia remains to be elucidated.
The aim of the present study was 1) to elucidate the optimal dose of the fentanyl IVPCA and 2) to evaluate the association between postoperative pain relief and the patient's satisfaction.
Materials and Methods

Patients and Study Design
The study protocol was approved by the Institutional The achievement of pain relief and the degree of postoperative nausea and vomiting (PONV) were analyzed as follows. Pain scores were assessed on a 3-point scale (0:
no pain, 1: manageable pain, and 2: intolerable pain). The use of anti-emetic drugs during surgery, the incidence of PONV, the requirement for nonsteroidal anti-inflammatory drugs (NSAIDs) for postoperative pain, and the cessation of IVPCA were also analyzed. Moreover, the relationship between the use of anti-emetic drugs during surgery and PONV/cessation of IVPCA was analyzed.
Respiratory depression was defined as <10 breaths/min or oxygen saturation value via pulse oximeter (SpO2) <90%.
Second, we further attempted to elucidate the optimal opioid doses of IVPCA analgesia in a prospective study. on pain 12 . The score of the HADS ranged from 0 to 21, and assesses whether the symptoms of anxiety/depression are absent (0 7), possible (8 10), or severe (11 21) 13 .
Anesthetic and Surgical Management
Standard monitoring was applied to patients upon ar- The IVPCA was applied during the first 24 h after the completion of surgery. The amount of fentanyl used in this study was determined in reference to previous reports 14 19 . Fentanyl at either 15 μg/mL (F15 group) or 30 μg/mL (F30 group) was administered into each pump.
As mentioned above, the IVPCA device was initially programmed to deliver fentanyl at a basal rate of 1.0 mL/h and a bolus dose of 1.0 mL, with a lockout time of 10 min. Patients were instructed to push the button for IVPCA whenever they felt pain. In both groups, NSAIDs 
Statistical Analysis
The For the prospective study, a power calculation based on VAS scores from a previous study 14 , with a statistical power of 80% and α<0.05, identified that a minimum Table 2 ).
From the observations mentioned above, we further sought to elucidate the optimal regimen for IVPCA in a prospective study. The demographic data of the patients are shown in Table 3 . In this prospective study, 43 patients (F15, n=21; F30, n=22) completed the study protocol. Four patients were excluded from the study because of IVPCA cessation due to severe nausea or vomiting (F15, n=2; F30, n=2). There were no significant differences in baseline variables between the groups ( Table 3 ).
In terms of the VAS score ( Table 4) .
Fentanyl use via IVPCA, button-hit counts, and the requirements for NSAIDs and antiemetic drugs are listed in Table 5 . Increased fentanyl consumption was observed in the F30 group compared to the F15 group, whereas there were no significant differences in the other variables.
The HADS and global and dimensional QoR-40J scores (see description in Materials and Methods) are presented in Table 6 . The HADS scores and the preoperative global and dimensional QoR-40J scores showed no significant differences between the groups. On postoperative days 1 and 2, however, the dimensional QoR-40J scores of pain subscales were significantly better (higher) in the F30 group than in the F15 group (p=0.021, p=0.024, respectively). However, the scores at the other time points did not differ between the two groups. In addition, there was no statistically significant difference in the incidence of side effects between the two groups ( Table 7) .
Lastly, we analyzed the correlation among the scores of 
Discussion
Pain is one of the most common complications associated with patient discomfort during the early postoperative period 15 . Postoperative pain can increase the mortality rate and the risk of adverse effects on multiple organs, complication incidence, and the development of chronic PONV was the most frequent side effect of opioid administration with a reported incidence of 20% 30% 17, 18 ; the previously reported incidence was higher than that in our study (18%). This difference was possibly due to dis- similarities in the protocol. Using higher doses of opioids may increase the incidence of PONV. Thus, in our prospective study, we used an anti-emetic drug during surgery to prevent PONV. Unexpectedly, the postoperative onset of PONV was 25%, and the actual rate of IVPCA cessation due to the postsurgical use of antiemetic drugs was 8%, as was the IVPCA cessation rate in the retrospective study. Notably, a higher fentanyl concentration did not significantly increase the incidence of PONV, and no significant differences in any side effects were observed between the two groups, or in the retrospective study and the previous study.
It has been reported that the quality of recovery from anesthesia and surgery is one of the factors that is directly associated with patients' satisfaction 12, 15, 19, 20 . Likewise, postoperative discomfort and complications could lead to later feeding, ambulation, and a prolonged hospital stay. The QoR-40 is the best instrument for assessing the recovery of patients who have undergone surgery or have undergone anesthesia 9 . Efforts towards precisely measuring and evaluating the QoR-40 could improve the overall quality of recovery and enhance patient satisfaction 9 . In our study, we used the Japanese version of the QoR-40 (QoR-40J), which has been tested for its validity, reliability, and feasibility in clinical evaluations of postoperative recovery 12 . The QoR-40J pain scores on postoperative days 1 and 2 tended to be better in the F30 than in the F15 group. In an investigation of each category on both postoperative days, we found that an improvement in the emotional state category on day 1 was also notable on day 2. The same result was observed for the global QoR-40J. As our treatment schedule included the use of This study has some limitations. This study was conducted to compare different fentanyl doses allocated to the 2 subject groups; therefore, a non-opioid treatment was not evaluated. The inclusion of a non-opioid group may have led to different results regarding pain, side effects, and patient satisfaction. Secondly, we could not evaluate pain conditions at a later time than postoperative day 2. Lastly, this study was conducted using a relatively small number of patients. Consequently, additional well-designed clinical studies with larger sample sizes are warranted to evaluate the efficacy and safety of this mode of analgesia.
Thus, in conclusion, the postoperative pain as well as the physical and emotional quality of recovery in patients who have undergone laparoscopic cholecystectomy can be alleviated by sufficient doses of opioids.
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